Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Aurobindo Pharma Limited announced obtaining the last approval from the US Food & Drug Administration (USFDA) for Rivaroxaban Tablets USP, 2.5 mg. DSIJ Intelligence-1 / Monday, April 14, 2025 0 167 Article rating: 5.0 The biosimilars division alongside niche product development represents Aurobindo Pharma's main focus areas where its 1500 scientists dedicate their efforts. Read more
Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 201 Article rating: 4.5 The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. Read more
46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why 46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 165 Article rating: 5.0 The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. Read more
Emcutix and WiQo Sign Exclusive Licensing Partnership to Revolutionize Derma-cosmetic Treatments in India Emcutix and WiQo Sign Exclusive Licensing Partnership to Revolutionize Derma-cosmetic Treatments in India The stock is up by 20 per cent from its 52-week low of Rs 911.75 per share. DSIJ Intelligence-1 / Tuesday, April 1, 2025 0 167 Article rating: 5.0 The stock is up by 20 per cent from its 52-week low of Rs 911.75 per share. Read more
From Rs 5.82 to Rs 31.96 per share in 294 days: Pharma penny stock hit 5 per cent upper circuit on March 24 From Rs 5.82 to Rs 31.96 per share in 294 days: Pharma penny stock hit 5 per cent upper circuit on March 24 The stock gave multibagger returns of 449 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence-1 / Monday, March 24, 2025 0 615 Article rating: 3.6 The stock gave multibagger returns of 449 per cent from its 52-week low of Rs 5.82 per share. Read more